KEY TAKEAWAY: The Internet has become a petri dish for bad/fake news. Here are some facts about prescription drugs and health that everyone should be aware of. Continue reading
KEY TAKEAWAY: Physicians and patients are not happy with electronic health records. That was the overwhelming takeaway from a day and half of qualitative research that, at times, became a megaphone for the displeasure of the current state of EHR’s. Continue reading
KEY TAKEAWAY: According to a MyTherapy 2015 survey, 96% of pharma apps have less than 100k downloads, 50% have only been updated once or never and 48% of users leave no good reviews. Should pharma walk away from apps? No! Continue reading
KEY TAKEAWAY: Pharma is ingrained in a culture of meetings and presentations. It’s been that way for over 20 years and is part of a matrix environment that shares decision making and waters down key initiatives. However, DTC marketers can ensure success by asking these three questions. Continue reading
KEY TAKEAWAY: As part of a study, they gave 2,000 U.S. workers, ranging in age from 18 to 81, a list of 17 benefits and asked them how heavily they would weigh the options when deciding between a high-paying job and a lower-paying job with more perks. Better health, dental, and vision insurance topped the list, with 88% of respondents saying that they would give this benefit “some consideration” (34%) or “heavy consideration” (54%) when choosing a job. Health insurance is the most expensive benefit to provide, with an average cost of $6,435 per employee for individual coverage, or $18,142 for family coverage. Continue reading
Here’s what will happen if the American Health Care Act becomes law. Tens of millions of Americans will lose health coverage and tens of thousands of people will die every year who otherwise would have lived. It’s time for the voices that have been silent to yell and stop this insanity before it’s too late. Continue reading
- KEY TAKEAWAY: Over the past seven years, generic drugs increased their share of total prescriptions filled from 66 percent to 82 percent, while brand drugs’ share of total prescriptions declined from 34 percent to 18 percent.